Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C38H80N |
| Molecular Weight | 551.0485 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 1 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC
InChI
InChIKey=OGQYPPBGSLZBEG-UHFFFAOYSA-N
InChI=1S/C38H80N/c1-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-37-39(3,4)38-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-2/h5-38H2,1-4H3/q+1
Distearyl dimethyl ammonium bromide (or dimethyldioctadecylammonium bromide (or DDA), a quaternary ammonium salt, that stimulates immune responses and binds to antigens. DDA enhances the immunogenicity of the soluble antigen. It was shown, that complexes of DDA and antigen were effective in eliciting a delayed hypersensitivity reaction, which was desirable for an antitumor effect. Besides, as a part of liposomal adjuvants, DDA can modulate T-helper 1-immune responses.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Liposomes based on dimethyldioctadecylammonium promote a depot effect and enhance immunogenicity of soluble antigen. | 2010-03-03 |
|
| Interaction of antigens with dimethyldioctadecylammonium bromide, a chemically defined biological response modifier. | 1982-12 |
|
| The enhancement of humoral and cellular immune responses by dimethyldioctadecylammonium bromide. | 1980-02 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
251IW5I21C
Created by
admin on Mon Mar 31 18:08:10 GMT 2025 , Edited by admin on Mon Mar 31 18:08:10 GMT 2025
|
PRIMARY | |||
|
1311550
Created by
admin on Mon Mar 31 18:08:10 GMT 2025 , Edited by admin on Mon Mar 31 18:08:10 GMT 2025
|
PRIMARY | RxNorm | ||
|
DB14143
Created by
admin on Mon Mar 31 18:08:10 GMT 2025 , Edited by admin on Mon Mar 31 18:08:10 GMT 2025
|
PRIMARY | |||
|
251IW5I21C
Created by
admin on Mon Mar 31 18:08:10 GMT 2025 , Edited by admin on Mon Mar 31 18:08:10 GMT 2025
|
PRIMARY | |||
|
C015831
Created by
admin on Mon Mar 31 18:08:10 GMT 2025 , Edited by admin on Mon Mar 31 18:08:10 GMT 2025
|
PRIMARY | |||
|
14357-21-2
Created by
admin on Mon Mar 31 18:08:10 GMT 2025 , Edited by admin on Mon Mar 31 18:08:10 GMT 2025
|
PRIMARY | |||
|
DTXSID00859191
Created by
admin on Mon Mar 31 18:08:10 GMT 2025 , Edited by admin on Mon Mar 31 18:08:10 GMT 2025
|
PRIMARY | |||
|
7880
Created by
admin on Mon Mar 31 18:08:10 GMT 2025 , Edited by admin on Mon Mar 31 18:08:10 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD
